Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

In situ tetramer staining reveals the presence of islet antigen-reactive CD8+ T cells in pancreatic islets from deceased type 1 diabetes patients.

• Publication year

  2012

• Venue

  Journal of Experimental Medicine

• Publication date

  2012-01-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/jem.20111187PMID 22213807PMCID 3260877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type 1 diabetes: etiology, immunology, and therapeutic strategies.

  2011cited by this paper
• Prediction and prevention of Type 1 diabetes mellitus

  2011cited by this paper
• Dimorphic histopathology of long-standing childhood-onset diabetes

  2010cited by this paper
• Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

  2010cited by this paper
• Banting Lecture 2009: An Unfinished Journey: Molecular Pathogenesis to Prevention of Type 1A Diabetes

  2010cited by this paper
• Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

  2010cited by this paper
• Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study

  2010influential reference
• Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ

  2010cited by this paper
• Histopathology of type 1 diabetes: old paradigms and new insights.

  2009cited by this paper
• Analysis of islet inflammation in human type 1 diabetes

  2009influential reference
• Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

  2008cited by this paper
• The beta cell population in type 1 diabetes.

  2008cited by this paper
• Equivalent Specificity of Peripheral Blood and Islet-Infiltrating CD8+ T Lymphocytes in Spontaneously Diabetic HLA-A2 Transgenic NOD Mice1

  2008cited by this paper
• Human Clonal CD8 Autoreactivity to an IGRP Islet Epitope Shared between Mice and Men

  2007cited by this paper
• Screening for Insulitis in Adult Autoantibody-Positive Organ Donors

  2007cited by this paper
• Identical β Cell-Specific CD8+ T Cell Clonotypes Typically Reside in Both Peripheral Blood Lymphocyte and Pancreatic Islets1

  2007cited by this paper
• Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

  2005cited by this paper
• Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes

  2005cited by this paper
• Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.

  2005cited by this paper
• Physiopathology and genetics of vitiligo.

  2005cited by this paper
• Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.

  2005cited by this paper
• A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes.

  2004cited by this paper
• Identification of a β-Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes

  2003cited by this paper
• Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes.

  2003cited by this paper
• Faculty Opinions recommendation of Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.

  2003cited by this paper
• Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.

  2003cited by this paper
• Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes

  2003cited by this paper
• Molecular anatomy of antigen-specific CD8+ T cell engagement and synapse formation in vivo

  2002cited by this paper
• Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific.

  2001cited by this paper
• A pyramid approach to subpixel registration based on intensity

  1998cited by this paper
• Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

  1995cited by this paper
• Determinant spreading and the dynamics of the autoimmune T-cell repertoire.

  1993cited by this paper
• Acute pancreatitis

  1988cited by this paper
• Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus.

  1987cited by this paper
• The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

  1986influential reference
• Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus

  1965influential reference

• Cross-tissue transcriptome-wide association identify novel T1D susceptibility genes and drug candidates

  2026cites this paper
• Clinical parameters and emerging biomarkers of partial remission in pediatric type 1 diabetes: a systematic review.

  2026cites this paper
• Proinsulin-Loaded Nanoparticles Suppress Insulitis and Induce Temporary Diabetes Remission

  2026cites this paper
• Shed light on molecular immunogenetic pathophysiology of type 1 diabetes to improve advanced treatment strategies.

  2025cites this paper
• Molecular and Inflammatory Etiologies of ß Cell Dysfunction in Type 1 Diabetes.

  2025cites this paper
• Nanomedicine targeting the PD-1/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance

  2025cites this paper
• Insulitis and exocrinitis in autoantibody-positive non-diabetic individuals: role of HLA genotypes.

  2025cites this paper
• CD8+ T Cells You Should Know about in Autoimmunity: Current Paradigms of T Cell Pathogenesis in Autoimmune Disease

  2025cites this paper
• The antigen presentation landscape of cytokine-stressed human pancreatic islets

  2025cites this paper
• The role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implications.

  2025cites this paper
• CXCL12 as a Potential Hub Gene for N-Acetylcysteine Treatment of T1DM Liver Disease

  2025cites this paper
• TCL1A in naïve B cells as a therapeutic target for type 1 diabetes

  2025cites this paper
• Matching model with mechanism: Appropriate rodent models for studying various aspects of diabetes pathophysiology.

  2025cites this paper
• Target Discovery to Diabetes Therapy - TXNIP From Bench to Bedside with NIDDK.

  2025cites this paper
• Monoclonal Antibodies to a Variable Fragment of the T-Cell Receptor—At the Service of Science and Medicine

  2025cites this paper
• (TCRαβ+) Double-Negative T Cells in Type 1 Diabetes Mellitus

  2025cites this paper
• Long non-coding RNAs as a novel source of beta cell autoantigens in type 1 diabetes

  2025cites this paper
• ST8Sia6 overexpression protects pancreatic β cells from spontaneous autoimmune diabetes in nonobese diabetic mice

  2025cites this paper
• Protective IFIH1 variant reduces immune-mediated islet stress and dysfunction in a type 1 diabetes genetic background

  2025cites this paper
• Gut-tropic α4β7+CD8+ T cells contribute to pancreatic β cell destruction in type 1 diabetes

  2025cites this paper
• Tissue Resident and Infiltrating Immune Cells: Their Influence on the Demise of Beta Cells in Type 1 Diabetes

  2025influential citation
• Imaging mass cytometry reveals early β-cell dysfunction and changes in immune signatures during type 1 diabetes progression in human pancreata

  2025cites this paper
• RIPK1 regulates β-cell fate via actions on gene expression and kinase signaling in a mouse model of β-cell self-reactivity

  2025cites this paper
• Type I Interferons in health and disease-Molecular aspects and clinical implications.

  2025cites this paper
• Tissue-Resident Memory T Cells in Tumor Immunity and Immunotherapy of Digestive System Tumors

  2025cites this paper
• Clone-Resolved Chemical Depletion of T cells via Cellular Proximity Chemistry.

  2025cites this paper
• Dysfunctional β-cell autophagy induces β-cell stress and enhances islet immunogenicity

  2025cites this paper
• Rice bran extract attenuates cognitive impairment by enhancing pancreatic β-cell insulin secretion in STZ-induced diabetic rats targeting the PPARγ/PDX1 pathway

  2025cites this paper
• Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?

  2025cites this paper
• A vascular-associated fibroblastic cell controls pancreatic islet immunity.

  2025cites this paper
• DNA repair and inflammatory response genes play a central role in protecting patients with long-standing type 1 diabetes from vascular complications.

  2025cites this paper
• The pathophysiology, presentation and classification of Type 1 diabetes

  2025cites this paper
• The perfect storm: unraveling the interplay of genetic predisposition and viral triggers in type 1 diabetes pathogenesis

  2025cites this paper
• Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices

  2025cites this paper
• Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.

  2025cites this paper
• Coxsackievirus B infection invokes unique cell-type-specific responses in primary human pancreatic islets

  2025cites this paper
• The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32.

  2024cites this paper
• Comprehensive characterization of islet remodeling in development and in diabetes using mass cytometry.

  2024cites this paper
• Human Vascularized Macrophage-Islet Organoids to Model Immune-Mediated Pancreatic β cell Pyroptosis upon Viral Infection

  2024cites this paper
• Temporal Alterations in CD8+ T Cells During the Progression from Stage 1 to Stage 3 Type 1 Diabetes.

  2024cites this paper
• Network approach reveals preferential T-cell and macrophage association with α-linked β-cells in early stage of insulitis in NOD mice

  2024influential citation
• Gamma-aminobutyric acid for delaying type 1 diabetes mellitus: an update

  2024cites this paper
• Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus

  2024cites this paper
• Advancing Animal Models of Human Type 1 Diabetes.

  2024cites this paper
• Untangling the genetics of beta cell dysfunction and death in type 1 diabetes

  2024cites this paper
• Network approach reveals preferential T-cell and macrophage association with α-linked β-cells in early stage of insulitis in NOD mice

  2024cites this paper
• Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes

  2024cites this paper
• Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset

  2024cites this paper
• Reduced expression of central innate defense molecules in pancreatic biopsies from subjects with Type 1 diabetes

  2024cites this paper
• Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.

  2024cites this paper
• Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation.

  2024cites this paper
• Cracking the type 1 diabetes code: Genes, microbes, immunity, and the early life environment

  2024cites this paper
• The Immunology of type 1 diabetes

  2024cites this paper
• The Human Pancreas in Type 1 Diabetes: Lessons Learned from the Network of Pancreatic Organ Donors with Diabetes.

  2024cites this paper
• Coxsackievirus infection induces direct pancreatic β cell killing but poor antiviral CD8+ T cell responses

  2024cites this paper
• The role of B cells in the pathogenesis of type 1 diabetes

  2024cites this paper
• Association of the immunity genes with type 1 Diabetes Mellitus.

  2024cites this paper
• UTX Epigenetically Imposes a Cytolytic Effector Program in Autoreactive Stem-like CD8+ T cell Progenitors

  2024cites this paper
• Epitope Hierarchy in Type 1 Diabetes Pathogenesis.

  2024cites this paper
• Comprehensive alpha, beta, and delta cell transcriptomics reveal an association of cellular aging with MHC class I upregulation

  2024cites this paper
• An overview on the interaction between non-coding RNAs and CTLA-4 gene in human diseases

  2024cites this paper
• The immunomodulator effect of Stevia rebaudiana Bertoni mediated by TNF‐α and IL‐1β in peripheral blood in diabetic rats

  2024cites this paper
• A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging

  2024cites this paper
• Embryonic macrophages support endocrine commitment during human pancreatic differentiation.

  2024cites this paper
• Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation

  2024cites this paper
• Lymph nodes as gatekeepers of autoimmune diseases

  2024cites this paper
• EXTOD-Immune: a randomised controlled trial to investigate whether a remotely monitored, home-based exercise intervention can reduce disease activity in people with type 1 diabetes

  2024cites this paper
• Antigen-specific T cell responses in autoimmune diabetes

  2024cites this paper
• Lysosomal physiology and pancreatic lysosomal stress in diabetes mellitus

  2024cites this paper
• Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection

  2024cites this paper
• Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease

  2024cites this paper
• Mechanisms underlying the development of type 1 diabetes in ART-treated people living with HIV: an enigmatic puzzle

  2024cites this paper
• HLA A*24:02–restricted T cell receptors cross-recognize bacterial and preproinsulin peptides in type 1 diabetes

  2024cites this paper
• The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus

  2024influential citation
• How do immune cells shape type 1 diabetes? Insights from Mendelian randomization

  2024cites this paper
• Bridging the Gap Between Tolerogenic Dendritic Cells In Vitro and In Vivo: Analysis of Siglec Genes and Pathways Associated with Immune Modulation and Evasion

  2024cites this paper
• Interleukin-27 and Autoimmune Disorders: A Compressive Review of Immunological Functions

  2024cites this paper
• Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3+ Treg in the Small Intestine

  2023cites this paper
• Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?

  2023cites this paper
• Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells

  2023cites this paper
• The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes

  2023cites this paper
• Investigating immune profile by CyTOF in individuals with long-standing type 1 diabetes

  2023cites this paper
• Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.

  2023cites this paper
• The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes

  2023cites this paper
• Type 1 diabetes.

  2023cites this paper
• Differential expression of genes controlling lymphocyte differentiation and migration in two distinct endotypes of type 1 diabetes

  2023cites this paper
• RNA‐binding proteins in autoimmunity: From genetics to molecular biology

  2023cites this paper
• PPARs at the crossroads of T cell differentiation and type 1 diabetes

  2023cites this paper
• Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus.

  2023cites this paper
• Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes

  2023cites this paper
• The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes

  2023cites this paper
• Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes

  2023cites this paper
• Toll-like receptor 7 de fi ciency suppresses type 1 diabetes development by modulating B-cell differentiation and function

  2023cites this paper
• Identi fi cation of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors

  2023cites this paper
• The beta cell-immune cell interface in type 1 diabetes (T1D)

  2023cites this paper
• Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses

  2023cites this paper
• Development of an immunoassay for the simultaneous detection of GADA and ZnT8A in autoimmune diabetes using a ZnT8/GAD65 chimeric molecule

  2023cites this paper
• Stem cell-like memory T cells: Role in viral infections and autoimmunity

  2023cites this paper
• A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome

  2023cites this paper
• Immunomodulation by subcutaneously injected methacrylic acid-based hydrogels and tolerogenic dendritic cells in a mouse model of autoimmune diabetes.

  2023cites this paper